Shares of Sun Pharmaceutical Industries fell 3 per cent on the Bombay Stock Exchange after the company reported a 59 per cent year-on-year decline in consolidated net profit at Rs 912 crore in the second quarter of FY 2018, against Rs 2,235 crore in the year-ago period.
Weighed down by weak Q2, shares of drug maker declined as much as 3.01 per cent to touch an intra-day low of Rs 510.30 apiece on the Bombay Stock Exchange.
In a similar fashion, shares of the firm were trading 2.49 per cent lower at Rs 512.95 apiece on the National Stock Exchange.
Meanwhile, the broader benchmark BSE Sensex was trading at 32,858.72, down 83.15 points, or 0.25 per cent, at 11:30 hours.